封面
市場調查報告書
商品編碼
1529727

美國電子醫療市場規模、佔有率和趨勢分析報告:按產品、最終用途和細分市場預測,2024-2030 年

U.S. eHealth Market Size, Share & Trends Analysis Report By Product (Telemedicine, Health Information Systems, mHealth, ePharmacy), By End Use (Providers, Payers, Patients), And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國電子醫療市場的成長與趨勢:

Grand View Research, Inc.的最新報告顯示,到2030年,美國電子醫療市場規模預計將達到3,766億美元,2024年至2030年的複合年成長率為17.6%。

電子醫療保健市場的推動因素包括遠端醫療和人工智慧等持續的技術進步、對醫療保健服務的需求不斷增加、由於 COVID-19 大流行而加速採用、支持性法律規範以及以患者為中心的護理模式,這是由幾個關鍵因素推動的。此外,電子處方箋由於能夠簡化藥物管理並提高病患安全性,已成為電子醫療市場的顯著驅動力。醫療保健提供者可以透過電子方式向藥房發送準確、易於閱讀的處方箋,從而減少錯誤並提高效率。

電子處方箋系統還透過為患者提供方便的處方藥物和劑量說明來促進更好的用藥依從性,最終改善醫療保健行業的健康結果並節省成本。例如,禮來公司 (Eli Lilly) 於 2024 年 1 月推出了 LillyDirect,這是一個數位平台,旨在簡化針對糖尿病、肥胖和偏頭痛等疾病的患者購買某些藥物的流程。該平台將患者與獨立的遠距醫療提供者聯繫起來,並提供疾病管理資源,提供直接獲取藥物的機會,並消除了從醫生那裡獲取處方箋的傳統步驟。此外,交換醫療資訊(HIE)透過促進互通性並確保醫療機構之間的無縫資料交換以改善護理協調,顯著推動了電子醫療市場的發展。

HIE 透過提供全面的病患記錄來提高護理的連續性,從而實現更快的診斷和更好的結果。 HIE 透過消除手動資料輸入和重複檢查來簡化流程、減少重複並提高效率。 HIE 允許患者存取和共用其健康記錄,從而賦予患者權力,並有助於更好地參與和決策。例如,2023 年 12 月,安大略省 21 家醫院和醫療機構推出了由 Oracle Health 提供支援的安大略省 eHub 健康資訊交換 (HIE)。這個創新平台可以在參與的醫療機構之間無縫、安全地共用患者資料。透過利用安大略省 eHub,這些機構可以簡化管理流程,最大限度地減少管理成本,並加強護理協調,以改善患者的醫療保健結果。

此外,政府舉措也對市場成長做出了重大貢獻。例如,2023 年 5 月,美國衛生與公眾服務部 (HHS) 宣布聯邦在遠端醫療和遠端醫療處方方面具有靈活性,以確保患者持續獲得基本護理。這些靈活性最初是在 COVID-19 公共衛生緊急情況 (PHE) 期間實施的,後來透過《2023 年綜合撥款法》延長至 2024年終。主要條款包括在全國範圍內擴大遠距遠端醫療服務的覆蓋範圍,允許患者家用中接受醫療保險覆蓋的遠端醫療就診,以及無需前往醫療機構等。此外,對於無法使用智慧型手機或電腦等影像媒體的人來說,某些醫療保險遠端醫療諮詢現在可以使用電話等純音訊技術進行。

美國電子醫療市場報告亮點:

  • 以產品來看,醫療資訊系統領域佔比最大,2023年為42.0%。醫療保健支出的增加和IT基礎設施的改善推動了市場的成長。遠端患者監護日益成長的需求也促進了該領域的採用。
  • 受管理病患工作流程和資料的電子醫療解決方案帶來的效率的推動,供應商最終用途細分市場在 2023 年佔據最大佔有率,達到 53.1%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國電子醫療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 藥用食品市場價格分析
  • 產業分析
    • 使用者觀點分析
    • 主要最終用戶
  • 技術展望
  • 法律規範
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰與機會分析
  • 電子醫療市場分析工具
    • 波特的分析
    • PESTEL分析
  • 電子醫療產業重大交易及策略聯盟分析
  • COVID-19 的影響
  • 案例研究見解

第4章美國電子醫療市場:依產品估算及趨勢分析

  • 定義和範圍
  • 2023 年及 2030 年按產品分類的市場佔有率分析
  • 細分儀表板
  • 電子醫療市場:依產品分類,2018-2030
  • 遠端醫療
  • 健康資訊系統
  • 行動醫療
  • 網路藥局
  • 電子處方
  • 電腦化醫令系統(CPOE)

第5章美國電子醫療市場:最終用途預測與趨勢分析

  • 定義和範圍
  • 2023 年和 2030 年按最終用途分類的市場佔有率分析
  • 細分儀表板
  • 電子醫療市場:依最終用途分類,2018-2030 年
  • 提供者
  • 付款人
  • 病人

第6章 競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司市場佔有率分析
  • 企業熱力圖分析
  • 策略規劃
    • 擴張
    • 併購
    • 夥伴關係與協作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • CVS Health
    • Teladoc Health, Inc.
    • American Well
    • Veradigm LLC
    • UNITEDHEALTH GROUP
    • Medtronic
    • Epocrates
    • Telecare Corporation
    • Medisafe
    • Set Point Medical
    • IBM
    • Doximity, Inc.
    • LiftLabs
Product Code: GVR-4-68040-339-7

U.S. eHealth Market Growth & Trends:

The U.S. eHealth market size is expected to reach USD 376.6 billion by 2030, registering a CAGR of 17.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The eHealth market is driven by several key factors, including ongoing technological advancements like telemedicine and AI, increased demand for healthcare services, accelerated adoption due to the COVID-19 pandemic, supportive regulatory frameworks, a shift towards patient-centric care models, the cost-effectiveness of digital solutions, data analytics for patient health management, and improved global connectivity. Furthermore, e-prescription is a notable driver of the eHealth market due to its ability to streamline medication management and improve patient safety. It enables healthcare providers to electronically send accurate and legible prescriptions to pharmacies, reducing errors and enhancing efficiency.

E-prescription systems also facilitate better medication adherence by providing patients convenient access to their prescribed medications and dosage instructions, ultimately leading to improved health outcomes and cost savings in the healthcare industry. For instance, in January 2024, Eli Lilly introduced LillyDirect, a digital platform designed to streamline purchasing specific medications for patients with prescriptions addressing conditions like diabetes, obesity, and migraine. This platform offers direct access to medicines by linking patients with independent Telehealth providers and providing resources for disease management, eliminating the traditional steps of obtaining a prescription from a physician. In addition, Health Information Exchange (HIE) significantly boosts the eHealth market by promoting interoperability and ensuring seamless data exchange among healthcare entities for improved care coordination.

HIE enhances care continuity by providing comprehensive patient records, leading to faster diagnoses and better outcomes. It streamlines processes, reduces redundancies, and improves efficiency by eliminating manual data entry and repeated tests. HIE empowers patients by allowing them to access and share their health records, contributing to better engagement and decision-making. For instance, in December 2023, a group comprising 21 Ontario hospitals and healthcare facilities launched the Ontario eHub Health Information Exchange (HIE) powered by Oracle Health. This innovative platform enables seamless and secure sharing of patient data among participating healthcare organizations. By leveraging the Ontario eHub, these entities can streamline administrative processes, minimize overhead costs, and enhance care coordination to improve patient healthcare outcomes.

Moreover, the government's initiatives significantly contributed to market growth. For instance, in May 2023, the U.S. Department of Health and Human Services (HHS) announced federal flexibilities regarding telehealth and telemedicine prescriptions to ensure ongoing access to essential care for patients. Initially implemented during the COVID-19 Public Health Emergency (PHE), these flexibilities were extended through the end of 2024 via the Consolidated Appropriations Act of 2023. Key provisions include expanded access to telehealth services nationwide, allowing patients to receive Medicare-covered telehealth visits from their homes, and eliminating the need for travel to healthcare facilities. Furthermore, certain Medicare telehealth consultations can now be conducted using audio-only technology, like telephones, for individuals unable to utilize audio and video mediums, such as smartphones or computers.

U.S. eHealth Market Report Highlights:

  • Based on products, the healthcare information systems segment held the largest share of 42.0% in 2023. The market growth is attributed to increasing healthcare spending and improvements in IT infrastructure. In addition, the growing need for remote patient monitoring is increasing its adoption
  • The providers end use segment accounted for the largest share of 53.1% in 2023, driven by the efficiencies delivered by the eHealth solutions in managing patient workflows and data

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. eHealth Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Pricing Analysis Around the Medical Food Market
  • 3.3. Industry Analysis
    • 3.3.1. User Perspective Analysis
    • 3.3.2. Key End Users
  • 3.4. Technology Outlook
  • 3.5. Regulatory Framework
  • 3.6. Market Dynamics
    • 3.6.1. Market Drivers Analysis
      • 3.6.1.1. Increasing need to manage regulatory compliance
      • 3.6.1.2. Rising healthcare costs
      • 3.6.1.3. Increasing prevalence of chronic disease
      • 3.6.1.4. Rising adoption of digital healthcare
      • 3.6.1.5. Growing need for patient-centric healthcare delivery
    • 3.6.2. Market Restraints Analysis
    • 3.6.3. Industry Challenges and Opportunity Analysis
  • 3.7. eHealth Market Analysis Tools
    • 3.7.1. Porter's Analysis
      • 3.7.1.1. Bargaining power of the suppliers
      • 3.7.1.2. Bargaining power of the buyers
      • 3.7.1.3. Threats of substitution
      • 3.7.1.4. Threats from new entrants
      • 3.7.1.5. Competitive rivalry
    • 3.7.2. PESTEL Analysis
      • 3.7.2.1. Political landscape
      • 3.7.2.2. Economic and Social landscape
      • 3.7.2.3. Technological landscape
      • 3.7.2.4. Environmental landscape
      • 3.7.2.5. Legal landscape
  • 3.8. Major Deals & Strategic Alliances Analysis in the eHealth Industry
  • 3.9. Impact of COVID-19
  • 3.10. Case Study Insights

Chapter 4. U.S. eHealth Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. eHealth Market: By Product, 2018 to 2030
  • 4.5. Telemedicine
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Health Information Systems
    • 4.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.1. Electronic Health Record

4.6.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.6.1.2. Electronic Medical Record

4.6.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.6.1.3. Patient Engagement Solution

4.6.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.6.1.4. Population Health Management

4.6.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

  • 4.7. mHealth
    • 4.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.1. Monitoring services

4.7.1.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.7.1.2. Diagnosis services

4.7.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.7.1.3. Healthcare Systems Strengthening Services

4.7.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

      • 4.7.1.4. Others

4.7.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

  • 4.8. ePharmacy
    • 4.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.9. E-Prescribing
    • 4.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.10. Computerized Physician Order Entry
    • 4.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. U.S. eHealth Market: End Use Estimates& Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. eHealth Market: By End Use, 2018 to 2030
  • 5.5. Providers
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Payers
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Patients
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Market Share Analysis
  • 6.4. Company Heat Map Analysis
  • 6.5. Strategy Mapping
    • 6.5.1. Expansion
    • 6.5.2. Mergers & Acquisition
    • 6.5.3. Partnerships & Collaborations
    • 6.5.4. New Product Launches
    • 6.5.5. Research And Development
  • 6.6. Company Profiles
    • 6.6.1. CVS Health
      • 6.6.1.1. Participant's Overview
      • 6.6.1.2. Financial Performance
      • 6.6.1.3. Product Benchmarking
      • 6.6.1.4. Recent Developments
    • 6.6.2. Teladoc Health, Inc.
      • 6.6.2.1. Participant's Overview
      • 6.6.2.2. Financial Performance
      • 6.6.2.3. Product Benchmarking
      • 6.6.2.4. Recent Developments
    • 6.6.3. American Well
      • 6.6.3.1. Participant's Overview
      • 6.6.3.2. Financial Performance
      • 6.6.3.3. Product Benchmarking
      • 6.6.3.4. Recent Developments
    • 6.6.4. Veradigm LLC
      • 6.6.4.1. Participant's Overview
      • 6.6.4.2. Financial Performance
      • 6.6.4.3. Product Benchmarking
      • 6.6.4.4. Recent Developments
    • 6.6.5. UNITEDHEALTH GROUP
      • 6.6.5.1. Participant's Overview
      • 6.6.5.2. Financial Performance
      • 6.6.5.3. Product Benchmarking
      • 6.6.5.4. Recent Developments
    • 6.6.6. Medtronic
      • 6.6.6.1. Participant's Overview
      • 6.6.6.2. Financial Performance
      • 6.6.6.3. Product Benchmarking
      • 6.6.6.4. Recent Developments
    • 6.6.7. Epocrates
      • 6.6.7.1. Participant's Overview
      • 6.6.7.2. Financial Performance
      • 6.6.7.3. Product Benchmarking
      • 6.6.7.4. Recent Developments
    • 6.6.8. Telecare Corporation
      • 6.6.8.1. Participant's Overview
      • 6.6.8.2. Financial Performance
      • 6.6.8.3. Product Benchmarking
      • 6.6.8.4. Recent Developments
    • 6.6.9. Medisafe
      • 6.6.9.1. Participant's Overview
      • 6.6.9.2. Financial Performance
      • 6.6.9.3. Product Benchmarking
      • 6.6.9.4. Recent Developments
    • 6.6.10. Set Point Medical
      • 6.6.10.1. Participant's Overview
      • 6.6.10.2. Financial Performance
      • 6.6.10.3. Product Benchmarking
      • 6.6.10.4. Recent Developments
    • 6.6.11. IBM
      • 6.6.11.1. Participant's Overview
      • 6.6.11.2. Financial Performance
      • 6.6.11.3. Product Benchmarking
      • 6.6.11.4. Recent Developments
    • 6.6.12. Doximity, Inc.
      • 6.6.12.1. Participant's Overview
      • 6.6.12.2. Financial Performance
      • 6.6.12.3. Product Benchmarking
      • 6.6.12.4. Recent Developments
    • 6.6.13. LiftLabs
      • 6.6.13.1. Participant's Overview
      • 6.6.13.2. Financial Performance
      • 6.6.13.3. Product Benchmarking
      • 6.6.13.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 U.S. ehealth market, by Product, 2018 - 2030 (USD Million)
  • Table 4 U.S. ehealth market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 eHealth Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (Part 1)
  • Fig. 9 Segment Snapshot (Part 2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 eHealth- Market Size and Growth Prospects (USD Billion)
  • Fig. 12 eHealth Market : Industry Value Chain Analysis
  • Fig. 13 eHealth Market : Market Dynamics
  • Fig. 14 eHealth Market : PORTER's Analysis
  • Fig. 15 eHealth Market : PESTEL Analysis
  • Fig. 16 eHealth Market Share by product 2023 & 2030 (USD Billion)
  • Fig. 17 eHealth Market ,by product: Market Share, 2023 & 2030
  • Fig. 18 Telemedicine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 19 Health Information Systems Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 20 Electronic Health Record Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 21 Electronic Medical Record Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 22 Patient Engagement Solution Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 23 Population Health Management Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 24 mHealth Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 25 Monitoring services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 26 Diagnosis services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 27 Healthcare Systems Strengthening Services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 28 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 29 ePharmacy Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 30 E-Prescribing Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 31 Computerized Physician Order Entry Market Estimates & Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 eHealth Market, by End Use: Key Takeaways
  • Fig. 33 eHealth Market, by End Use: Market Share, 2023 & 2030
  • Fig. 34 Providers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 35 Payers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 36 Patients Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
  • Fig. 37 Key Company Categorization
  • Fig. 38 Company Market Positioning
  • Fig. 39 Key Company Market Share Analysis, 2023
  • Fig. 40 Strategic Framework